Coromandel Reports 30% Revenue Jump to ₹31,827 Cr for FY26

CHEMICALS
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Coromandel Reports 30% Revenue Jump to ₹31,827 Cr for FY26
Overview

Coromandel International's FY26 results show a strong 30% revenue growth to ₹31,827 crore, fueled by expanded capacities and retail network. However, consolidated PAT declined 8% to ₹1,898 crore, impacted by raw material volatility and currency movements. The company declared a ₹11 per share dividend, signaling operational resilience despite margin pressures.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Financial Performance Highlights

Coromandel International reported strong revenue growth for the fiscal year ended March 31, 2026, with consolidated revenue jumping 30% year-on-year to ₹31,827 crore. However, consolidated Profit After Tax (PAT) saw an 8% decline, falling to ₹1,898 crore for the same period.

Driving Revenue Growth: Expansion and Network

This substantial revenue increase was propelled by expanded capacities and a growing retail footprint. The company completed or scaled up key projects, including new sulphuric and phosphoric acid plants at Kakinada, enhancing backward integration and efficiency. Its agri-retail network has also expanded to 1200 centres, improving farmer engagement and market reach.

Profitability Under Pressure

Despite robust sales, profitability faced headwinds from volatile raw material prices and currency movements. These factors contributed to the dip in consolidated PAT. Coromandel is also focusing on diversifying into specialty nutrients and crop protection to reduce its reliance on the traditional fertilizer segment and achieve better margin stability.

Operational Developments and Shareholder Returns

The company's Board declared a final dividend of ₹2 per share, making the total dividend for FY26 ₹11 per share. This indicates confidence amid margin pressures. New manufacturing capacities for acid production are now operational, supporting backward integration. The fertilizer granulation capacity expansion project is progressing, with completion targeted for Q4 FY26-27. The crop protection business continues to show solid growth, boosting the top line.

Industry Comparisons and Key Risks

Coromandel operates in a dynamic sector. Peers like UPL Ltd and Rallis India have also managed challenges such as input cost volatility and supply chain disruptions. Companies in the fertilizer space, including Chambal Fertilisers, face sector-specific risks tied to government subsidy policies. Coromandel's nutrient business is sensitive to raw material prices and currency fluctuations. A significant risk highlighted was an 80% drop in Q4 PAT, alongside the overall 8% decline in full-year PAT.

Financial Snapshot: FY25 vs. FY26

  • Consolidated Total Income: Grew from ₹24,444 crore in FY25 to ₹31,827 crore in FY26.
  • Consolidated PAT: Declined from ₹2,055 crore in FY25 to ₹1,898 crore in FY26.
  • Standalone PAT: Increased from ₹1,941 crore in FY25 to ₹2,009 crore in FY26.

What to Watch Next

Investors will closely monitor the timeline for the commissioning of the fertiliser granulation capacity expansion project in Kakinada. The contribution of the new acid plants to profitability and cost structure will also be a key focus. Continued growth from the expanded agri-retail network and management's approach to navigating input cost volatility and currency risks are important indicators. Future capital allocation strategies will also be watched.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.